Predominant cone photoreceptor dysfunction in a hyperglycaemic model of non-proliferative diabetic retinopathy

DMM Disease Models and Mechanisms

Volumn 3, Issue 3-4, 2010, Pages 236-245

  Alvarez, Yolanda ^a   Chen, Kenneth ^a   Reynolds, Alison L ^a   Waghorne, Nora ^a   O'Connor, John J ^a   Kennedy, Breandán N ^a  

^a UNIVERSITY COLLEGE DUBLIN   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BLOOD RETINA BARRIER; DIABETIC RETINOPATHY; ELECTRORETINOGRAM; HYPERGLYCEMIA; NEUROPROTECTION; NONHUMAN; PHOTORECEPTOR CELL; PRIORITY JOURNAL; RETINA NERVE CELL; ZEBRA FISH;

AGING; ANIMALS; BASEMENT MEMBRANE; BLOOD-RETINAL BARRIER; DIABETIC RETINOPATHY; DISEASE MODELS, ANIMAL; ELECTRORETINOGRAPHY; GLUCOSE; HYPERGLYCEMIA; RETINAL CONE PHOTORECEPTOR CELLS; RETINAL DEGENERATION; RETINAL VESSELS; ZEBRAFISH;

DANIO RERIO;

EID: 77949439159     PISSN: 17548403     EISSN: 17548411     Source Type: Journal    
DOI: 10.1242/dmm.003772     Document Type: Article

References (61)

1. Alvarez, Y., Cederlund, M. L., Cottell, D. C., Bill, B. R., Ekker, S. C., Torres-Vazquez, J., Weinstein, B. M., Hyde, D. R., Vihtelic, T. S. and Kennedy, B. N. (2007). Genetic determinants of hyaloid and retinal vasculature in zebrafish. BMC Dev. Biol. 7, 114.
2. Barber, A. J., Lieth, E., Khin, S. A., Antonetti, D. A., Buchanan, A. G. and Gardner, T. W. (1998). Neural apoptosis in the retina during experimental and human diabetes. Early onset and effect of insulin. J. Clin. Invest. 102, 783-791.
3. Bayliss, P. E., Bellavance, K. L., Whitehead, G. G., Abrams, J. M., Aegerter, S., Robbins, H. S., Cowan, D. B., Keating, M. T., O'Reilly, T., Wood, J. M. et al. (2006). Chemical modulation of receptor signaling inhibits regenerative angiogenesis in adult zebrafish. Nat. Chem. Biol. 2, 265-273.
4. Bresnick, G. H. and Palta, M. (1987). Predicting progression to severe proliferative diabetic retinopathy. Arch. Ophthalmol. 105, 810-814.
5. Brownlee, M. (2001). Biochemistry and molecular cell biology of diabetic complications. Nature 414, 813-820.
6. Campochiaro, P. A. (2007). Targeted pharmacotherapy of retinal diseases with ranibizumab. Drugs Today (Barc.) 43, 529-537.
7. Cao, R., Jensen, L. D., Soll, I., Hauptmann, G. and Cao, Y. (2008). Hypoxia-induced retinal angiogenesis in zebrafish as a model to study retinopathy. PLoS ONE 3, e2748.
8. Carrasco, E., Hernandez, C., Miralles, A., Huguet, P., Farres, J. and Simo, R. (2007). Lower somatostatin expression is an early event in diabetic retinopathy and is associated with retinal neurodegeneration. Diabetes Care 30, 2902-2908.
9. Carrasco, E., Hernandez, C., de Torres, I., Farres, J. and Simo, R. (2008). Lowered cortistatin expression is an early event in the human diabetic retina and is associated with apoptosis and glial activation. Mol. Vis. 14, 1496-1502.
10. Chan, J., Bayliss, P. E., Wood, J. M. and Roberts, T. M. (2002). Dissection of angiogenic signaling in zebrafish using a chemical genetic approach. Cancer Cell 1, 257-267.
11. Cho, N. C., Poulsen, G. L., Ver Hoeve, J. N. and Nork, T. M. (2000). Selective loss of Scones in diabetic retinopathy. Arch. Ophthalmol. 118, 1393-1400.
12. Daley, M. L., Watzke, R. C. and Riddle, M. C. (1987). Early loss of blue-sensitive color vision in patients with type I diabetes. Diabetes Care 10, 777-781.
13. Engelhard, K., Muller-Forell, W. and Werner, C. (2008). [Therapy of head trauma]. Anaesthesist. 57, 1219-1231.
14. Feit-Leichman, R. A., Kinouchi, R., Takeda, M., Fan, Z., Mohr, S., Kern, T. S. and Chen D. F. (2005). Vascular damage in a mouse model of diabetic retinopathy, relation to neuronal and glial changes. Invest. Ophthalmol Vis. Sci. 46, 4281-4287.
15. Frank, R. N. (2004). Diabetic retinopathy. N. Engl. J. Med. 350, 48-58.
16. Frank, R. N. (2009). Treating diabetic retinopathy by inhibiting growth factor pathways. Curr. Opin. Investig. Drugs 10, 327-335.
17. Fraser, R. B., Waite, S. L., Wood, K. A. and Martin, K. L. (2007). Impact of hyperglycemia on early embryo development and embryopathy, in vitro experiments using a mouse model. Hum. Reprod. 22, 3059-3068.
18. Gardner, T. W., Antonetti, D. A., Barber, A. J., LaNoue, K. F. and Levison, S. W. (2002). Diabetic retinopathy, more than meets the eye. Surv. Ophthalmol. 47 Suppl. 2, S253-S262.
19. Garner, A. (1970). Pathology of diabetic retinopathy. Br. Med. Bull. 26, 137-142.
20. Gleeson, M., Connaughton, V. and Arneson, L. S. (2007). Induction of hyperglycaemia in zebrafish (Danio rerio) leads to morphological changes in the retina. Acta. Diabetol. 44, 157-163.
21. Greenstein, V. C., Holopigian, K., Hood, D. C., Seiple, W. and Carr, R. E. (2000). The nature and extent of retinal dysfunction associated with diabetic macular edema. Invest. Ophthalmol. Vis. Sci. 41, 3643-3654.
22. Haselton, F. R., Dworska, E. J. and Hoffman, L. H. (1998). Glucose-induced increase in paracellular permeability and disruption of beta-receptor signaling in retinal endothelium. Invest. Ophthalmol. Vis. Sci. 39, 1676-1684.
23. Hernandez, C. and Simo, R. (2007). Strategies for blocking angiogenesis in diabetic retinopathy, from basic science to clinical practice. Expert. Opin. Investig. Drugs 16, 1209-1226.
24. Hong, C. C. (2009). Large-scale small-molecule screen using zebrafish embryos. Methods Mol. Biol. 486, 43-55.
25. Ihnat, M. A., Thorpe, J. E., Kamat, C. D., Szabo, C., Green, D. E., Warnke, L. A., Lacza, Z., Cselenyak, A., Ross, K., Shakir, S. et al. (2007). Reactive oxygen species mediate a cellular 'memory' of high glucose stress signalling. Diabetologia 50, 1523-1531.
26. Jin, X., Xue, A., Zhao, Y., Qin, Q., Dong, X. D. and Qu, J. (2007). Efficacy and safety of intravenous injection of lidocaine in the treatment of acute primary angle-closure glaucoma, a pilot study. Graefes Arch. Clin. Exp. Ophthalmol. 245, 1611-1616.
27. Juen, S. and Kieselbach, G. F. (1990). Electrophysiological changes in juvenile diabetics without retinopathy. Arch. Ophthalmol. 108, 372-375.
28. Kinkel, M. D. and Prince, V. E. (2009). On the diabetic menu, zebrafish as a model for pancreas development and function. BioEssays 31, 139-152.
29. Kitambi, S. S., McCulloch, K. J., Peterson, R. T. and Malicki, J. J. (2009). Small molecule screen for compounds that affect vascular development in the zebrafish retina. Mech. Dev. 126, 464-477.
30. Klein, R., Klein, B. E., Moss, S. E., Davis, M. D. and DeMets, D. L. (1984). The Wisconsin epidemiologic study of diabetic retinopathy. III. Prevalence and risk of diabetic retinopathy when age at diagnosis is 30 or more years. Arch. Ophthalmol. 102, 527-532.
31. Kurtenbach, A., Mayser, H. M., Jagle, H., Fritsche, A. and Zrenner, E. (2006). Hyperoxia, hyperglycemia, and photoreceptor sensitivity in normal and diabetic subjects. Vis. Neurosci. 23, 651-661.
32. Lam, D. S., Chua, J. K., Tham, C. C. and Lai, J. S. (2002). Efficacy and safety of immediate anterior chamber paracentesis in the treatment of acute primary angle-closure glaucoma, a pilot study. Ophthalmology 109, 64-70.
33. Li, Q., Zemel, E., Miller, B. and Perlman, I. (2002). Early retinal damage in experimental diabetes, electroretinographical and morphological observations. Exp. Eye Res. 74, 615-625.
34. Makino, S., Kunimoto, K., Muraoka, Y., Mizushima, Y., Katagiri, K. and Tochino, Y. (1980). Breeding of a non-obese, diabetic strain of mice. Jikken Dobutsu 29, 1-13.
35. Mandal, A. K., Ping, T., Caldwell, S. J., Bagnell, R. and Hiebert, L. M. (2006). Electron microscopic analysis of glucose-induced endothelial damage in primary culture, possible mechanism and prevention. Histol. Histopathol. 21, 941-950.
36. Mandrekar, N. and Thakur, N. L. (2009). Significance of the zebrafish model in the discovery of bioactive molecules from nature. Biotechnol. Lett. 31, 171-179.
37. Martin, P. M., Roon, P., Van Ells, T. K., Ganapathy, V. and Smith, S. B. (2004). Death of retinal neurons in streptozotocin-induced diabetic mice. Invest Ophthalmol. Vis. Sci. 45, 3330-3336.
38. Morello, C. M. (2007). Etiology and natural history of diabetic retinopathy, an overview. Am. J. Health Syst. Pharm. 64, S3-S7.
39. Mortlock, K. E., Chiti, Z., Drasdo, N., Owens D. R. and North, R. V. (2005). Silent substitution S-cone electroretinogram in subjects with diabetes mellitus. Ophthalmic Physiol. Opt. 25, 392-399.
40. Nakhooda, A. F., Like, A. A., Chappel, C. I., Murray, F. T. and Marliss, E. B. (1977). The spontaneously diabetic Wistar rat. Metabolic and morphologic studies. Diabetes 26, 100-112.
41. Pampfer, S., Cordi, S., Vanderheyden, I., Van Der Smissen, P., Courtoy, P. J., Van Cauwenberge, A., Alexandre, H., Donnay, I. and De Hertogh, R. (2001). Expression and role of Bcl-2 in rat blastocysts exposed to high D-glucose. Diabetes 50, 143-149.
42. Parisi, V. and Uccioli, L. (2001). Visual electrophysiological responses in persons with type 1 diabetes. Diabetes Metab. Res. Rev. 17, 12-18.
43. Park, S. H., Park, J. W., Park, S. J., Kim, K. Y., Chung, J. W., Chun, M. H. and Oh, S. J. (2003). Apoptotic death of photoreceptors in the streptozotocin-induced diabetic rat retina. Diabetologia 46, 1260-1268.
44. Portha, B., Giroix, M. H., Serradas, P., Gangnerau, M. N., Movassat, J., Rajas, F., Bailbe, D., Plachot, C., Mithieux, G. and Marie, J. C. (2001). beta-cell function and viability in the spontaneously diabetic GK rat, information from the GK/Par colony. Diabetes 50 Suppl. 1, S89-S93.
45. Rees D. A. and Alcolado, J. C. (2005). Animal models of diabetes mellitus. Diabet Med. 22, 359-370.
46. Ruberte, J., Ayuso, E., Navarro, M., Carretero, A., Nacher, V., Haurigot, V., George, M., Llombart, C., Casellas, A., Costa, C. et al. (2004). Increased ocular levels of IGF-1 in transgenic mice lead to diabetes-like eye disease. J. Clin. Invest. 113, 1149-1157.
47. Saint-Geniez, M., Maharaj, A. S., Walshe, T. E., Tucker, B. A., Sekiyama, E., Kurihara, T., Darland, D. C., Young, M. J. and D'Amore, P. A. (2008). Endogenous VEGF is required for visual function, evidence for a survival role on muller cells and photoreceptors. PLoS ONE 3, e3554.
48. Shen, W. Y., Lai, Y. K., Lai, C. M., Binz, N., Beazley, L. D., Dunlop, S. A. and Rakoczy, P. E. (2006). Pathological heterogeneity of vasoproliferative retinopathy in transgenic mice overexpressing vascular endothelial growth factor in photoreceptors. Adv. Exp. Med. Biol. 572, 187-193.
49. Simo, R. and Hernandez, C. (2008). Intravitreous anti-VEGF for diabetic retinopathy, hopes and fears for a new therapeutic strategy. Diabetologia 51, 1574-1580.
50. Simo, R., Carrasco, E., Garcia-Ramirez, M. and Hernandez, C. (2006). Angiogenic and antiangiogenic factors in proliferative diabetic retinopathy. Curr. Diabetes Rev. 2, 71-98.
51. Sone, H., Okuda, Y., Kawakami, Y., Hanatani, M., Suzuki, H., Kozawa, T., Honmura, S. and Yamashita, K. (1996). Vascular endothelial growth factor level in aqueous humor of diabetic patients with rubeotic glaucoma is markedly elevated. Diabetes Care 19, 1306-1307.
52. Sone, H., Kawakami, Y., Okuda, Y., Sekine, Y., Honmura, S., Matsuo, K., Segawa, T., Suzuki, H. and Yamashita, K. (1997). Ocular vascular endothelial growth factor levels in diabetic rats are elevated before observable retinal proliferative changes. Diabetologia 40, 726-730.
53. van Eeden, P. E., Tee, L. B., Lukehurst, S., Lai, C. M., Rakoczy, E. P., Beazley, L. D. and Dunlop, S. A. (2006). Early vascular and neuronal changes in a VEGF transgenic mouse model of retinal neovascularization. Invest. Ophthalmol. Vis. Sci. 47, 4638-4645.
54. Vinores, S. A., Sen, H. and Campochiaro, P. A. (1992). An adenosine agonist and prostaglandin E1 cause breakdown of the blood-retinal barrier by opening tight junctions between vascular endothelial cells. Invest. Ophthalmol. Vis. Sci. 33, 1870-1878.
55. Westerfield, M. (2000). The zebrafish book. A guide for the laboratory use of zebrafish (Danio rerio). 4th ed, in (Univ. of Oregon Press E ed).
56. Wilkinson-Berka, J. L. and Miller, A. G. (2008). Update on the treatment of diabetic retinopathy. ScientificWorldJournal 8, 98-120.
57. Wolter, J. R. (1961). Diabetic retinopathy. Am. J. Ophthalmol. 51, 1123-1141.
58. Wong, K. Y., Gray, J., Hayward, C. J., Adolph, A. R. and Dowling, J. E. (2004). Glutamatergic mechanisms in the outer retina of larval zebrafish, analysis of electroretinogram b- and d-waves using a novel preparation. Zebrafish 1, 121-131.
59. Wong, T. Y., Klein, R., Islam, F. M., Cotch, M. F., Folsom, A. R., Klein, B. E., Sharrett, A. R. and Shea, S. (2006). Diabetic retinopathy in a multi-ethnic cohort in the United States. Am. J. Ophthalmol. 141, 446-455.
60. Yamamoto, S., Kamiyama, M., Nitta, K., Yamada, T. and Hayasaka, S. (1996). Selective reduction of the S cone electroretinogram in diabetes. Br. J. Ophthalmol. 80, 973-975.
61. Zeng, X. X., Ng, Y. K. and Ling, E. A. (2000). Neuronal and microglial response in the retina of streptozotocin-induced diabetic rats. Vis. Neurosci. 17, 463-471.